Mosaic software agreement enables easy extension of Evotec’s systems and supports further growth
Olivier Casamitjana, Senior Vice President and Global Compound Management Head at Evotec said: “This agreement aligns Titian as a solution provider with our plans to expand our business further, enabling easy extension of Evotec’s systems and ensuring Titian can respond dynamically to our operational needs.”
Evotec has relied on Mosaic software for sample management and tracking for nearly 20 years. This is not the first collaboration between Evotec and Titian; projects include the co-development of ground-breaking technologies such as acoustic dispensing workflows, and recently on inter-organisational synchronisation of inventory so that Evotec can share live inventory data and live shipment updates securely with each customer. This latter capability is included in the latest release of Mosaic software, version 9.0.
Nicholas Spurrett, CEO at Titian Software, commented, “This is a significant investment by Evotec, which is a vote of confidence in the Mosaic software platform and in Titian being a trusted partner and foundation for Evotec to build on. The new agreement - offering unlimited licenses, pre-purchase service days for ‘support on tap,’ and new technologies underpinning our services - provides a flexible way of working to suit the evolving needs of drug discovery.”
David Booth, Director, Major Accounts, Europe, Titian Software, and Olivier Casamitjana, Senior Vice President, Head of Global Compound Management, Evotec.
About Evotec SE
Evotec is a life science company with a unique business model that delivers on its mission to discover and develop highly effective therapeutics and make them available to the patients. The Company’s multimodality platform comprises a unique combination of innovative technologies, data and science for the discovery, development, and production of first-in-class and best-in-class pharmaceutical products. Evotec leverages this “Data-driven R&D Autobahn to Cures” for proprietary projects and within a network of partners including all Top 20 Pharma and over 800 biotechnology companies, academic institutions, as well as other healthcare stakeholders. Evotec has strategic activities in a broad range of currently underserved therapeutic areas, including e.g. neurology, oncology, as well as metabolic and infectious diseases. Within these areas of expertise, Evotec aims to create the world-leading co-owned pipeline for innovative therapeutics and has to-date established a portfolio of more than 200 proprietary and co-owned R&D projects from early discovery to clinical development. Evotec operates globally with more than 4,900 highly qualified people. The Company’s 17 sites offer highly synergistic technologies and services and operate as complementary clusters of excellence. For additional information please go to www.evotec.com and follow us on Twitter @Evotec and LinkedIn.
About Titian Software
Titian Software is the industry leader in providing sample management software for life science applications. Trusted by pharma, biotech, and CRO institutions worldwide, Titian offers software products and consultancy services that improve the supply of samples - small molecules, reagents, DNA, proteins, antibodies, cell lines, blood, serum, tissues - to vital research processes. Titian’s sample management software, Mosaic, improves throughput, response times, cost efficiencies, error rates, and sample conservation, laying the foundation for discovery and laboratory optimization initiatives.
Learn more about Titian Software at: https://www.titian.co.uk/